CN105012590A - Mammary gland hyperplasia preventing and treating pharmaceutical composition - Google Patents
Mammary gland hyperplasia preventing and treating pharmaceutical composition Download PDFInfo
- Publication number
- CN105012590A CN105012590A CN201410150000.XA CN201410150000A CN105012590A CN 105012590 A CN105012590 A CN 105012590A CN 201410150000 A CN201410150000 A CN 201410150000A CN 105012590 A CN105012590 A CN 105012590A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- mammary gland
- preventing
- cyclomastopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention provides a mammary gland hyperplasia preventing and treating pharmaceutical composition, which is mainly prepared from the following bulk drugs by weight: 20-30 parts of frankincense, 5-15 parts of myrrh, 10-20 parts of mirabilite, 5-10 parts of raw rhizoma arisaematis, and 20-40 parts of polistes mandarinus saussure. According to the present invention, the mammary gland hyperplasia preventing and treating pharmaceutical composition has characteristics of reasonable compatibility, fine drug selection, mild drug nature, no toxic-side effect and significant treatment effect, and can be used for treatment of mammary gland hyperplasia diseases, routine mammary gland conditioning, and prevention of mammary gland diseases.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of pharmaceutical composition preventing and treating cyclomastopathy.
Background technology
Female mammary gland disease is one of principal disease of present stage harm women's health.According to World Health Organization (WHO) (WHO) global female mammary gland sickness survey data statistics, China about has the women of 50% to suffer from mastopathy in various degree.Common female mammary gland disease has: cyclomastopathy, mammitis, acute mastitis, breast carcinoma etc.Wherein cyclomastopathy is the modal cystic hyperplasia of breast of women, and seven sickness rate account for the first place of mastopathy, and the sickness rate of this disease is in the trend risen year by year in recent years, and the age also more and more becomes younger.Cyclomastopathy refers to breast epithelium and proliferation of fibrous tissue, mammary gland tissue conduit and newborn lobule degeneration structurally and the growth of Progressive symmetric erythrokeratodermia connective tissue, and its pathogenic factor is mainly due to endocrine hormone imbalance.Mastopathy constitutes great threat to the Health and Living of women.
Summary of the invention
The object of the present invention is to provide a kind of pharmaceutical composition preventing and treating cyclomastopathy.
The technical solution adopted in the present invention is:
Prevent and treat a pharmaceutical composition for cyclomastopathy, its crude drug primarily of following weight portion is made: Olibanum 20 ~ 30 parts, Myrrha 5 ~ 15 parts, 10 ~ 20 parts, Natrii Sulfas, Arisaema Cum Bile 5 ~ 10 parts, Nidus Vespae 20 ~ 40 parts.
As preferably, the described pharmaceutical composition preventing and treating cyclomastopathy is made primarily of the crude drug of following weight portion: Olibanum 25 parts, Myrrha 10 parts, 15 parts, Natrii Sulfas, Arisaema Cum Bile 5 parts, Nidus Vespae 25 parts.
Described pharmaceutical composition makes external preparation.Described external preparation is powder, water preparation, cream, Emulsion, gel or essence etc.
Above-described preparation method of preventing and treating the pharmaceutical composition of cyclomastopathy, comprises the steps:
(1) take Olibanum, Myrrha, Natrii Sulfas, Arisaema Cum Bile, Nidus Vespae respectively by formula, after Mechanical Crushing, add 2 ~ 5 times of volume 60% ~ 85% ethanol water reflux, extract, 1 ~ 3 time, each 1 ~ 2 hour;
(2) merge extractive liquid, decompression recycling ethanol is extremely without alcohol taste, and filter, discard filtering residue, released liquor, medicinal liquid concentrate under reduced pressure at low temperature obtains ointment;
(3) add pharmaceutically acceptable carrier or adjuvant in ointment, be prepared into exterior-applied formulation.
Beneficial effect of the present invention is:
Pharmaceutical composition compatibility of the present invention rationally, select YAOJING thin, and the property of medicine is gentle, can not produce toxic and side effects, can be used for the treatment of hyperplasia of mammary glands, evident in efficacy.Also can be used for daily mammary gland conditioning, the generation of prevention mastopathy.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further detailed explanation, but do not form any limitation of the invention.The change of anyone limited number of time done within the scope of the claims in the present invention, still in claims of the present invention.
embodiment 1
Prevent and treat a pharmaceutical composition for cyclomastopathy, be made up of the crude drug of following weight portion: Olibanum 20 parts, Myrrha 15 parts, 10 parts, Natrii Sulfas, Arisaema Cum Bile 8 parts, Nidus Vespae 20 parts.
embodiment 2
Prevent and treat a pharmaceutical composition for cyclomastopathy, be made up of the crude drug of following weight portion: Olibanum 30 parts, Myrrha 5 parts, 20 parts, Natrii Sulfas, Arisaema Cum Bile 10 parts, Nidus Vespae 40 parts.
embodiment 3
Prevent and treat a pharmaceutical composition for cyclomastopathy, be made up of the crude drug of following weight portion: Olibanum 25 parts, Myrrha 10 parts, 15 parts, Natrii Sulfas, Arisaema Cum Bile 5 parts, Nidus Vespae 25 parts.
Prevent and treat the preparation method of the pharmaceutical composition of cyclomastopathy described in embodiment 1 ~ 3, comprise the steps:
(1) take Olibanum, Myrrha, Natrii Sulfas, Arisaema Cum Bile, Nidus Vespae respectively by formula, after Mechanical Crushing, add 2 ~ 5 times of volume 60% ~ 85% ethanol water reflux, extract, 1 ~ 3 time, each 1 ~ 2 hour;
(2) merge extractive liquid, decompression recycling ethanol is extremely without alcohol taste, and filter, discard filtering residue, released liquor, medicinal liquid concentrate under reduced pressure at low temperature obtains ointment;
(3) add pharmaceutically acceptable carrier or adjuvant in ointment, be prepared into exterior-applied formulation.
clinical case
Case 1: patient Lin Nvshi, 30 years old, be diagnosed as two newborn cyclomastopathy through certain hospital, after treatment, patient's subjective effect was not obvious.Look into breast and can touch streak lump, have tenderness.Use every day the pharmaceutical composition of the embodiment of the present invention 3 to be applied in breast surface, after 2 courses for the treatment of, patient's readme discomfort is alleviated.After continuing to use for 3 courses for the treatment of, patient is again through examination in hospital, and two breast is normal.After recovery from illness, Mrs Han continues to use medicine of the present invention and carries out daily conditioning, existing more than 1 year, does not have mastopathy to occur.
Case 4: patient Ms Zhang, 45 years old, suffer from cyclomastopathy more than 2 years, nodosity in breast, breast falling inflation is uncomfortable, pain.After using 2 courses for the treatment of of medicine of the invention process 3, pain slows down, and after continuing to use 6 courses for the treatment of, pain sense disappears, and breast checks normal thoroughly.Rear its continues to use medicine of the present invention and carries out daily conditioning, follows up a case by regular visits to 2 years without recurrence.
Claims (5)
1. prevent and treat a pharmaceutical composition for cyclomastopathy, its crude drug primarily of following weight portion is made: Olibanum 20 ~ 30 parts, Myrrha 5 ~ 15 parts, 10 ~ 20 parts, Natrii Sulfas, Arisaema Cum Bile 5 ~ 10 parts, Nidus Vespae 20 ~ 40 parts.
2. the pharmaceutical composition preventing and treating cyclomastopathy according to claim 1, is characterized in that, its crude drug primarily of following weight portion is made: Olibanum 25 parts, Myrrha 10 parts, 15 parts, Natrii Sulfas, Arisaema Cum Bile 5 parts, Nidus Vespae 25 parts.
3. the pharmaceutical composition preventing and treating cyclomastopathy according to claim 1 and 2, is characterized in that, described pharmaceutical composition makes external preparation.
4. the pharmaceutical composition preventing and treating cyclomastopathy according to claim 3, is characterized in that, described external preparation is powder, water preparation, cream, Emulsion, gel or essence etc.
5. the preparation method of preventing and treating the pharmaceutical composition of cyclomastopathy described in any one of Claims 1 to 4, comprises the steps:
(1) take Olibanum, Myrrha, Natrii Sulfas, Arisaema Cum Bile, Nidus Vespae respectively by formula, after Mechanical Crushing, add 2 ~ 5 times of volume 60% ~ 85% ethanol water reflux, extract, 1 ~ 3 time, each 1 ~ 2 hour;
(2) merge extractive liquid, decompression recycling ethanol is extremely without alcohol taste, and filter, discard filtering residue, released liquor, medicinal liquid concentrate under reduced pressure at low temperature obtains ointment;
(3) add pharmaceutically acceptable carrier or adjuvant in ointment, be prepared into exterior-applied formulation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410150000.XA CN105012590A (en) | 2014-04-15 | 2014-04-15 | Mammary gland hyperplasia preventing and treating pharmaceutical composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410150000.XA CN105012590A (en) | 2014-04-15 | 2014-04-15 | Mammary gland hyperplasia preventing and treating pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105012590A true CN105012590A (en) | 2015-11-04 |
Family
ID=54403135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410150000.XA Pending CN105012590A (en) | 2014-04-15 | 2014-04-15 | Mammary gland hyperplasia preventing and treating pharmaceutical composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105012590A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109248257A (en) * | 2018-11-19 | 2019-01-22 | 亳州市君臣佐使药业有限公司 | A kind of Chinese materia medica preparation of dispersing swelling and dissipating binds and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101336953A (en) * | 2008-08-06 | 2009-01-07 | 崔凤玉 | Production method of traditional Chinese medicine for treating soft-tissue swell |
| CN103599286A (en) * | 2013-11-11 | 2014-02-26 | 于明儒 | Traditional Chinese medicine composition for treating fibroid |
-
2014
- 2014-04-15 CN CN201410150000.XA patent/CN105012590A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101336953A (en) * | 2008-08-06 | 2009-01-07 | 崔凤玉 | Production method of traditional Chinese medicine for treating soft-tissue swell |
| CN103599286A (en) * | 2013-11-11 | 2014-02-26 | 于明儒 | Traditional Chinese medicine composition for treating fibroid |
Non-Patent Citations (2)
| Title |
|---|
| 何天有: "芒硝的外用经验", 《辽宁中医杂志》 * |
| 李艳慧等: "穴位贴敷治疗子宫肌瘤30例疗效观察", 《新中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109248257A (en) * | 2018-11-19 | 2019-01-22 | 亳州市君臣佐使药业有限公司 | A kind of Chinese materia medica preparation of dispersing swelling and dissipating binds and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101716214A (en) | Medical composition containing dandelion extract as well as novel application and preparation method thereof | |
| CN102362924B (en) | Medicinal composition for treating ophthalmic diseases and preparation method thereof | |
| CN105168984A (en) | Chinese herbal compound eye plaster for treating ophthalmic diseases | |
| CN105012590A (en) | Mammary gland hyperplasia preventing and treating pharmaceutical composition | |
| CN102274317A (en) | Chinese medicinal composition for treating cancers and preparation method thereof | |
| CN109172700A (en) | For treating the Chinese medicine preparation, preparation method and application of ophthalmology disease | |
| CN104587304B (en) | A kind of medicine for the treatment of Simple Obesity and uses thereof | |
| CN103479737A (en) | Traditional Chinese medicine composition for treating senile cutaneous pruritus and application thereof | |
| CN103330815B (en) | Traditional Chinese medicine spray for curing sexual dysfunction | |
| CN105148150A (en) | Healthcare tea and making method thereof | |
| CN103933169B (en) | A kind of Chinese medicine composition for fumigation treatment deafness and tinnitus and its preparation method and application | |
| CN103920100B (en) | A kind of pharmaceutical composition treating cyclomastopathy | |
| CN104436077B (en) | A kind of pharmaceutical composition for the treatment of cyclomastopathy | |
| CN103520331A (en) | Traditional Chinese medicinal preparation for treating liver-stomach disharmony type chronic gastritis and preparation method for traditional Chinese medicinal preparation | |
| CN102727834B (en) | Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof | |
| CN103550423B (en) | A kind of pharmaceutical composition for the treatment of xerophthalmia | |
| CN102552765B (en) | Medicament for treating hyperplasia of mammary glands | |
| CN101979076A (en) | Compound combination medicament for treating cerebral metastatic tumor and preparation method and application thereof | |
| CN101829162A (en) | Pharmaceutical composition for treating allergic rhinitis and preparation method thereof | |
| CN106668240A (en) | Pharmaceutical composition for treating vitreous opacity | |
| CN105434678A (en) | Composition for preventing and/or treating sub-health caused by using of electronic products | |
| CN104491554B (en) | A kind of medicine for treating mastitis and preparation method thereof | |
| CN104623492A (en) | Traditional Chinese medicine formula for treating chronic gastritis | |
| CN103239670B (en) | Chinese medicine effective part composition for treating breast hyperplasia and preparation method of Chinese medicine effective part composition | |
| CN102772470A (en) | External-application medicine for treating lung-heat rhinopolypus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151104 |